Literature DB >> 17942435

Evaluation of a new immunoassay for urinary ethyl glucuronide testing.

Michael Böttcher1, Olof Beck, Anders Helander.   

Abstract

AIMS: The minor ethanol metabolite ethyl glucuronide (EtG) is used as a sensitive and specific test for recent alcohol consumption with clinical and forensic applications. This study evaluated a new enzyme immunoassay (DRI-EtG EIA, Microgenics Corp.) for determination of the EtG concentration in urine samples.
METHODS: Evaluation was done using the kit calibrators (range 0-5.0 mg/L) and controls, an external quality control sample, and 400 consecutive urines from the routine samples pool. The measuring range was extended by dilution of urine samples with saline. Comparison was made with an established liquid chromatographic-mass spectrometric (LC-MS) method.
RESULTS: The intra- and inter-assay imprecision of the DRI-EtG EIA in the range 0.4-2.5 mg/L was <2.2% (coefficient of variation, CV), and the limit of quantification was <0.1 mg/L. For the 400 urine samples, the EtG concentrations obtained using the DRI-EtG EIA (mean 24.2 mg/L, range 0-830) and LC-MS method (mean 22.4 mg/L, range 0-959) showed an overall good and statistically significant agreement (r2 = 0.931, P < 0.0001).
CONCLUSIONS: These results indicated a high level of accuracy and selectivity of the DRI-EtG EIA for quantification of urinary EtG. In the absence of a commonly accepted cut-off limit for urinary EtG, a threshold of 0.5 mg/L (2.2 mumol/L) is proposed, to obtain a high sensitivity but avoid positive results due to unintentional ethanol exposure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942435     DOI: 10.1093/alcalc/agm153

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  17 in total

1.  Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker.

Authors:  Michael G McDonell; Donelle N Howell; Sterling McPherson; Jennifer M Cameron; Debra Srebnik; John M Roll; Richard K Ries
Journal:  J Appl Behav Anal       Date:  2012

2.  Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready?

Authors:  Peter Jatlow; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

3.  Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients.

Authors:  Scott H Stewart; David G Koch; Douglas M Burgess; Ira R Willner; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2012-06-22       Impact factor: 3.455

4.  Evaluation of ethyl glucuronide immunoassay urinalysis in five alcohol-dependent outpatients.

Authors:  Michael G McDonell; Debra Srebnik; Frank Angelo; Andrea M Sugar; Donelle Howell; Christina Rainey; John Roll; Robert Short; Richard Ries
Journal:  Am J Addict       Date:  2011-07-18

5.  A high-performance liquid chromatographic-tandem mass spectrometric method for the determination of ethyl glucuronide and ethyl sulfate in urine validated according to forensic guidelines.

Authors:  M E Albermann; F Musshoff; B Madea
Journal:  J Chromatogr Sci       Date:  2012-01       Impact factor: 1.618

6.  Ethyl glucuronide and ethyl sulfate in urine after consumption of various beverages and foods--misleading results?

Authors:  Frank Musshoff; Elena Albermann; Burkhard Madea
Journal:  Int J Legal Med       Date:  2010-09-14       Impact factor: 2.686

7.  Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients.

Authors:  Jessica M Lowe; Michael G McDonell; Emily Leickly; Frank A Angelo; Roger Vilardaga; Sterling McPherson; Debra Srebnik; John Roll; Richard K Ries
Journal:  Alcohol Clin Exp Res       Date:  2015-04-10       Impact factor: 3.455

Review 8.  [What ethanol metabolites as biological markers tell us about alcohol use].

Authors:  Friedrich Martin Wurst; Natasha Thon; Wolfgang Weinmann; Michel Yegles; Ulrich Preuss
Journal:  Wien Med Wochenschr       Date:  2013-12-10

9.  Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.

Authors:  Peter I Jatlow; Ann Agro; Ran Wu; Haleh Nadim; Benjamin A Toll; Elizabeth Ralevski; Christine Nogueira; Julia Shi; James D Dziura; Ismene L Petrakis; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

Review 10.  Liver Transplantation for Alcohol-Related Liver Disease.

Authors:  Narendra S Choudhary; Naveen Kumar; Sanjiv Saigal; Rahul Rai; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2016-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.